Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2000 Feb;59(2):110–115. doi: 10.1136/ard.59.2.110

Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls

I Gilboe 1, T Kvien 1, G Haugeberg 1, G Husby 1
PMCID: PMC1753071  PMID: 10666165

Abstract

OBJECTIVES—To examine bone mineral density (BMD) frequency of osteoporosis and reduced bone mass in systemic lupus erythematosus (SLE), and compare the data of the SLE patients with matched rheumatoid arthritis (RA) patients and healthy controls. Secondly, to study possible correlations between BMD, demographic and disease variables in the SLE patients.
METHODS—Measures of BMD assessed by dual energy x ray absorptiometry were obtained from 75 SLE patients aged ⩽ 70 years, 75 RA patients matched for age, sex and disease duration, and from 75 healthy controls matched for age, sex and geographical area. Disease activity and accumulated organ damage were assessed in the SLE patients.
RESULTS—The SLE patients had significantly lower BMD values at lumbar spine L2-L4 and hip, and higher frequency of osteoporosis at all sites of measurement compared with matched healthy controls. The matched SLE and RA patients had similar BMD, prevalence of osteoporosis and reduced bone mass. In the SLE patients BMD was more strongly correlated with accumulated organ damage than with markers of disease activity or duration. In multivariate analyses BMD was at all sites predicted by age and body mass, at lumbar spine also by the current corticosteroid dose.
CONCLUSION—The study showed reduced BMD in patients with SLE compared with matched healthy controls. Premenopausal women taking corticosteroids were especially affected. Furthermore, the BMD of matched SLE and RA patients was reduced to a similar extent.



Full Text

The Full Text of this article is available as a PDF (150.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Cummings S. R., Black D. M., Nevitt M. C., Browner W., Cauley J., Ensrud K., Genant H. K., Palermo L., Scott J., Vogt T. M. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993 Jan 9;341(8837):72–75. doi: 10.1016/0140-6736(93)92555-8. [DOI] [PubMed] [Google Scholar]
  3. Deodhar A. A., Woolf A. D. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol. 1996 Apr;35(4):309–322. doi: 10.1093/rheumatology/35.4.309. [DOI] [PubMed] [Google Scholar]
  4. Dhillon V. B., Davies M. C., Hall M. L., Round J. M., Ell P. J., Jacobs H. S., Snaith M. L., Isenberg D. A. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry. Ann Rheum Dis. 1990 Aug;49(8):624–626. doi: 10.1136/ard.49.8.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dykman T. R., Gluck O. S., Murphy W. A., Hahn T. J., Hahn B. H. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1985 Apr;28(4):361–368. doi: 10.1002/art.1780280402. [DOI] [PubMed] [Google Scholar]
  6. Formiga F., Moga I., Nolla J. M., Pac M., Mitjavila F., Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis. 1995 Apr;54(4):274–276. doi: 10.1136/ard.54.4.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gilboe I. M., Kvien T. K., Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol. 1999 Aug;26(8):1694–1700. [PubMed] [Google Scholar]
  8. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., Bacon P., Bombardieri S., Hanly J., Hay E. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 Mar;39(3):363–369. doi: 10.1002/art.1780390303. [DOI] [PubMed] [Google Scholar]
  9. Hall G. M., Spector T. D., Griffin A. J., Jawad A. S., Hall M. L., Doyle D. V. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum. 1993 Nov;36(11):1510–1516. doi: 10.1002/art.1780361105. [DOI] [PubMed] [Google Scholar]
  10. Hansen M., Halberg P., Kollerup G., Pedersen-Zbinden B., Hørslev-Petersen K., Hyldstrup L., Lorenzen I. Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment. Scand J Rheumatol. 1998;27(3):197–206. doi: 10.1080/030097498440813. [DOI] [PubMed] [Google Scholar]
  11. Houssiau F. A., Lefebvre C., Depresseux G., Lambert M., Devogelaer J. P., Nagant de Deuxchaisnes C. Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol. 1996 Mar;35(3):244–247. doi: 10.1093/rheumatology/35.3.244. [DOI] [PubMed] [Google Scholar]
  12. Kalla A. A., Fataar A. B., Jessop S. J., Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum. 1993 Dec;36(12):1726–1734. doi: 10.1002/art.1780361212. [DOI] [PubMed] [Google Scholar]
  13. Kalla A. A., Meyers O. L., Kotze T. J., Laubscher R. Corticosteroid therapy and bone mass--comparison of rheumatoid arthritis and systemic lupus erythematosus. S Afr Med J. 1994 Jul;84(7):404–409. [PubMed] [Google Scholar]
  14. Kalla A. A., Meyers O. L., Parkyn N. D., Kotze T. J. Osteoporosis screening--radiogrammetry revisited. Br J Rheumatol. 1989 Dec;28(6):511–517. doi: 10.1093/rheumatology/28.6.511. [DOI] [PubMed] [Google Scholar]
  15. Kanis J. A., Melton L. J., 3rd, Christiansen C., Johnston C. C., Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994 Aug;9(8):1137–1141. doi: 10.1002/jbmr.5650090802. [DOI] [PubMed] [Google Scholar]
  16. Kipen Y., Briganti E., Strauss B., Will R., Littlejohn G., Morand E. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol. 1999 Feb;26(2):310–317. [PubMed] [Google Scholar]
  17. Kipen Y., Buchbinder R., Forbes A., Strauss B., Littlejohn G., Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol. 1997 Oct;24(10):1922–1929. [PubMed] [Google Scholar]
  18. Kvien T. K., Glennås A., Knudsrød O. G., Smedstad L. M., Mowinckel P., Førre O. The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol. 1997;26(6):412–418. doi: 10.3109/03009749709065712. [DOI] [PubMed] [Google Scholar]
  19. Li E. K., Tam L. S., Young R. P., Ko G. T., Li M., Lau E. M. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol. 1998 Apr;37(4):405–410. doi: 10.1093/rheumatology/37.4.405. [DOI] [PubMed] [Google Scholar]
  20. Martin J. C., Munro R., Campbell M. K., Reid D. M. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol. 1997 Jan;36(1):43–49. doi: 10.1093/rheumatology/36.1.43. [DOI] [PubMed] [Google Scholar]
  21. Maury C. P., Teppo A. M. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum. 1989 Feb;32(2):146–150. doi: 10.1002/anr.1780320206. [DOI] [PubMed] [Google Scholar]
  22. McLeod J. F. Osteoporosis, cytokines, and glucocorticoids. Allergy Proc. 1993 Sep-Oct;14(5):363–364. doi: 10.2500/108854193778773967. [DOI] [PubMed] [Google Scholar]
  23. Peel N. F., Moore D. J., Barrington N. A., Bax D. E., Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis. 1995 Oct;54(10):801–806. doi: 10.1136/ard.54.10.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pons F., Peris P., Guañabens N., Font J., Huguet M., Espinosa G., Ingelmo M., Muñoz-Gomez J., Setoain J. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol. 1995 Aug;34(8):742–746. doi: 10.1093/rheumatology/34.8.742. [DOI] [PubMed] [Google Scholar]
  25. Ramsey-Goldman R., Dunn J. E., Huang C. F., Dunlop D., Rairie J. E., Fitzgerald S., Manzi S. Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum. 1999 May;42(5):882–890. doi: 10.1002/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  26. Ross P. D., Davis J. W., Epstein R. S., Wasnich R. D. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991 Jun 1;114(11):919–923. doi: 10.7326/0003-4819-114-11-919. [DOI] [PubMed] [Google Scholar]
  27. Sambrook P. N., Jones G. Corticosteroid osteoporosis. Br J Rheumatol. 1995 Jan;34(1):8–12. doi: 10.1093/rheumatology/34.1.8. [DOI] [PubMed] [Google Scholar]
  28. Segal L. G., Lane N. E. Osteoporosis and systemic lupus erythematosus: etiology and treatment strategies. Ann Med Interne (Paris) 1996;147(4):281–289. [PubMed] [Google Scholar]
  29. Seitz M., Hunstein W. Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus. Ann Rheum Dis. 1985 Jul;44(7):438–445. doi: 10.1136/ard.44.7.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  31. Tanaka Y., Watanabe K., Suzuki M., Saito K., Oda S., Suzuki H., Eto S., Yamashita U. Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus. J Clin Immunol. 1989 Sep;9(5):415–420. doi: 10.1007/BF00917107. [DOI] [PubMed] [Google Scholar]
  32. Uhlig T., Kvien T. K., Glennås A., Smedstad L. M., Førre O. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol. 1998 Jun;25(6):1078–1084. [PubMed] [Google Scholar]
  33. Ware J. E., Jr, Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–483. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES